Jul 2, 2019
Polypharmacy has long been thought to be linked to increased incidence of falls. A recent Canadian cohort study assessing community‐dwelling older adults included 5 years of follow‐up to assess this issue amongst people aged 65 years and older (n = 249; 76.6 ± 8.6 y;...
Jul 2, 2019
Discussion about the long term side effects of Proton pump inhibitors (PPIs) continues, but almost all meaningful data to date have been derived from pharmacoepidemiological studies based upon naturalistic observational techniques. A large randomized trial has now...
Jul 2, 2019
A great deal has been written about how older people who take PPIs for long periods of time may be susceptible to adverse events. A team of Australian pharmacist and nurse researchers has just published a study that examined the use of PPIs in residential aged care...
Jul 1, 2019
Medical Cannabis may impact opioid and benzodiazepine requirements for pain control, according to recent research from the USA. A single-center, retrospective cohort study evaluated opioid and benzodiazepine doses over a 6-month time period for patients using medical...
Jul 1, 2019
A recently published review has compared oral metronidazole and vancomycin for the treatment of mild-to-moderate C difficile infection. The authors found evidence of superior efficacy with vancomycin, and also a lower cost of treatment per case for hospitalized...
Jun 30, 2019
Recurrent Clostridium difficile infection has been defined as a relapse of symptoms within 2 -8 weeks of successful treatment of an initial episode, and depending upon interpretation is said to occur in up to 35% of people with C difficile infection. A recent review...
